방사성 의약품의 성장 기회

Emerging Interest from Big Pharma Players Is Pushing Industry Innovation Momentum

The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.

The report sheds light on technology innovations to make better radiopharmaceuticals. The radiopharmaceuticals industry is at the cusp of a high-confidence phase, with investors, CDMOs, and big pharmaceutical firms engaging in fundraising rounds, licensing agreements, acquisitions, and strategic collaborations. This research provides insights into partnerships, collaborations, acquisitions/mergers, and private funding activities that contribute to the growth of radiopharmaceuticals.

Key questions this report answers: What are the key drivers and challenges for the development of radiopharmaceuticals? What is the pace of clinical development in each segment? Who are the leading industry participants developing innovative radiopharmaceuticals? What does the funding and partnership landscape look like for radiopharmaceuticals? What are the growth opportunities in radiopharmaceuticals?

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?
• The Strategic Imperative 8
• The Impact of the Top 3 Strategic Imperatives on the Industry
• Growth Opportunities Fuel the Growth Pipeline Engine
• Research Methodology

Growth Opportunity Analysis

• Scope of Analysis
• Segmentation

Growth Generator

• Growth Drivers
• Growth Restraints
• Introduction: Radiopharmaceuticals Gaining Traction

Radiodiagnostics

• Radiodiagnostics
• PET Analysis for Oncology
• PET Imaging Radiopharmaceuticals
• SPECT Analysis for Radio Diagnostics
• Key Innovators-Radiodiagnostics

Radiotherapeutics

• Radiotherapeutics
• Comparative Analysis of Radiotherapies
• Overview of the Radiotherapeutics Pipeline
• Key Trends in Radiopharmaceuticals
• Radiopharmaceuticals-Innovator Spotlight
• Technological Innovation in Radiopharmaceuticals
• Targeting Strategies and Radiochemistry Advances-Innovations
• Novel Radioisotopes-Innovations
• Drug Delivery-Innovations

Strategic Insights

• Private Funding for Radiotherapeutics
• Overview of the Acquisition Landscape for Radiopharmaceuticals
• Partnership Landscape in Radiopharmaceuticals
• Key Insights
• Global M&A; Partnerships Landscape
• Radiopharma Companies on Global Map
• Insights from Radiopharmaceuticals Experts

Growth Opportunity Universe

• Growth Opportunity 1: Focus on Alpha Therapies
• Growth Opportunity 2: Focus on Radiotherapeutics
• Growth Opportunity 3: Focus on Novel Targets

Appendix

• PET Imaging Radiopharmaceuticals
• Clinical Pipeline Analysis of Key Industry Players-Radiotherapeutics
• Technology Readiness Levels TRL: Explanation

Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• Legal Disclaimer